Seventy patients benefited from molecular analysis with the local high throughput sequencing AML minimal panel searching for mutations of NPM1, FLT3ITD, IDH1, IDH2, ASXL1, RUNX1, TP53 at diagnosis. The gene discussed is NPM1; the disease is acute myeloid leukemia.